Schlosser Mario sold $4.3M of OSCR (indirect holdings)
Schlosser Mario sold 147,500 indirectly-held shares of Oscar Health, Inc. (OSCR) at an average of $29.38 ($28.95–$30.09, $4.33M total) across 9 trades on 2026-06-23 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A director sold 147,500 shares in open-market transactions at $28.9500–$30.0900 (weighted avg $29.3756), totaling ~$4.33M, under a pre-arranged Rule 10b5-1 plan; this is a sentiment datapoint rather than a fundamental catalyst.
Market read
Traders may monitor for follow-on insider activity, but the 10b5-1 framing suggests limited incremental information.
What to watch
The insider’s holdings drop to 0 shares, which can be interpreted as completion of a planned liquidity event; without additional context (e.g., other insiders, guidance), the trading signal is weak.
Background
The article is an SEC Form 4 insider transaction for Oscar Health, Inc. (OSCR) by director Mario Schlosser.
Ticker impact
Oscar Health disclosed a director open-market sale of 147,500 shares via a 10b5-1 plan, worth about $4.33M, filed June 25.
Likely limited immediate price impact; any effect would be sentiment-driven and modest unless accompanied by other news.
The filing is a primary Form 4 disclosure with transaction size and pricing range, but it explicitly states a pre-arranged 10b5-1 plan and the insider ends with 0 shares.
Market effects
No direct sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan and the trades occurred on June 23, the disclosure may be largely mechanical rather than a forward-looking bearish signal.
Key entities
- issuerOscar Health, Inc.
Subject of the Form 4 insider transaction; director sold shares under a 10b5-1 plan.
- insiderMario Schlosser
Director who executed the open-market sale; holdings after transaction: 0 shares.
